Premier Inc.

Those in support of the US FDA’s approval this year of Biogen, Inc. ’s Aduhelm (aducanumab) for the treatment of Alzheimer’s disease (AD) like to point out the parallels to the regulator’s approach i

A group of 11 Premier Inc. member health systems are set to have uninterrupted supply of 19 pharmaceutical products in the US, including several shortage-hit generic injectables, after the US-based

Pfizer Inc. has announced a partnership with Premier Inc. ’s ProvideGx program to supply five essential injectable drugs to healthcare providers in the US, including some medications that have been

Bipartisan drug shortage legislation is gaining traction in the US as coronavirus outbreak begins disrupting the pharmaceutical supply chain: There is a new bill in the House and growing stakeholder s